GIS
ZBH icon

Grayhawk Investment Strategies’s Zimmer Biomet ZBH Stock Holding History

Grayhawk Investment Strategies’s Portfolio ZBH Stock Details ZBH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q1 		– Sell
-4,661
Closed -$567K – 254
2023
Q4 		$567K Buy
+4,661
New +$520K 0.29% 79

Other funds holding ZBH

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Dodge & Cox
Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
American Century Companies
American Century Companies Kansas City, Missouri $194B AUM 35% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Grayhawk Investment Strategies's ZBH Position: Q1 2024 in Review

Grayhawk Investment Strategies sold out of Zimmer Biomet (ZBH) in Q1 2024, closing a stake of 4,661 shares — an estimated $567K sold.

Grayhawk Investment Strategies first reported a position in ZBH in Q4 2023 and held it in 1 quarter. The position peaked at $567K in Q4 2023. 1,011 funds tracked by Wall St. Rank hold ZBH as of Q1 2024.

  • Grayhawk Investment Strategies reported no remaining Zimmer Biomet position as of Q1 2024 after selling out during the quarter.
  • Grayhawk Investment Strategies sold 4,661 Zimmer Biomet shares in Q1 2024, an estimated $567K.
  • Grayhawk Investment Strategies first reported a position in Zimmer Biomet in Q4 2023 and held it in 1 quarter.
  • Grayhawk Investment Strategies's Zimmer Biomet position peaked at $567K in Q4 2023.
  • 1,011 funds tracked by Wall St. Rank held Zimmer Biomet as of Q1 2024.

Based on Grayhawk Investment Strategies's 13F filing for Q1 2024, filed 15 May 2024.